Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
University of Nebraska
Vastra Gotaland Region
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Travera Inc
Fudan University
Jonsson Comprehensive Cancer Center
German Cancer Research Center
Sun Yat-sen University
Institute of Cancer Research, United Kingdom
Fudan University
The Netherlands Cancer Institute
The Affiliated Hospital of Qingdao University
Oslo University Hospital
HRYZ Biotech Co.
Dana-Farber Cancer Institute